,31 Our present study revealed that compound DBH2 induced apoptosis in bone marrow cells from CML patients was almost twice fold compared to its effects on CD34+ LSC, indicating this small molecular might diminish the expansion of certain components of niche by activated apoptosis. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.